US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 42.040
  • +0.830+2.01%
Close Jan 30 16:00 ET
  • 42.730
  • +0.690+1.64%
Post 16:46 ET
3.59BMarket Cap-15.07P/E (TTM)

CRISPR Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jan 30, 2025

Based on 19 analysts giving stock ratings to CRISPR Therapeutics in the past 3 months

Buy

  • Buy

    52.63%

  • Hold

    36.84%

  • Sell

    10.53%

Price Target

Updated: Jan 30, 2025

The average CRISPR Therapeutics stock price target is 66.13 with a max estimate of 105.00 and a min estimate of 30.00

Review CRISPR Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Beijing HyperStrong Technology
688411
+229.21%
Yalian Machinery
001395
+159.43%
Merit Interactive
300766
+20.02%
4
Pansoft
300996
+20.01%
5
Sublime China Information
301299
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
China Concept Stocks
Tracking the US-listed Chinese companies.
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011